FDA.reportPublic FDA data

rasagiline 0.5 MG Oral Tablet [Azilect]

RxCUI
637218
RxNorm name
rasagiline 0.5 MG Oral Tablet [Azilect]
Display name
rasagiline 0.5 MG Oral Tablet [Azilect]
Full name
rasagiline 0.5 MG Oral Tablet [Azilect]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AzilectRASAGILINE MESYLATETeva Neuroscience, Inc.a40d0e73-3f9f-4b01-979d-402c9cdaeb602020-06-30Warnings, Adverse reactionsExact identifier
rxcui: 637218

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a40d0e73-3f9f-4b01-979d-402c9cdaeb60Azilect 0.5 MG Oral Tablet [PSN] · rasagiline 0.5 MG Oral Tablet [Azilect] [SBD] · Azilect 0.5 MG Oral Tablet [SY]325These highlights do not include all the information needed to use AZILECT ® safely and effectively. See full prescribing information for AZILECT . AZILECT (rasagiline) Tablets for Oral Use Initial U.S. Approval: 200620200630